Back to Search
KHALILA ARRINGTON, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1982630315Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PS35183(FL)
Research & Publications (14)
Repeat sternotomy in congenital heart surgery: no longer a risk factor.
PMID 18721579·Ann Thorac Surg·2008
8-other
Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors.
PMID 17804227·Bioorg Med Chem Lett·2007
8-other
An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis.
PMID 17101792·Mol Cell Biol·2007
8-other
3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6.
PMID 16978863·Bioorg Med Chem Lett·2006
8-other
Encouraging results for the Contegra conduit in the problematic right ventricle-to-pulmonary artery connection.
PMID 16935124·J Thorac Cardiovasc Surg·2006
8-other
Preliminary experience with the MicroMed DeBakey pediatric ventricular assist device.
PMID 16638555·Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu·2006
8-other
Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.
PMID 16439123·Bioorg Med Chem Lett·2006
8-other
Kinesin spindle protein (KSP) inhibitors. Part 3: synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility.
PMID 16439122·Bioorg Med Chem Lett·2006
7-preclinical
Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding.
PMID 14698157·Bioorg Med Chem Lett·2004
7-preclinical
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors.
PMID 12941314·Bioorg Med Chem Lett·2003
7-preclinical
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics.
PMID 12443771·Bioorg Med Chem Lett·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5201 RAYMOND ST
ORLANDO, FL 32803 - Phone
- (407) 629-1599
Quick Facts
- NPI
- 1982630315
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile